Image

ULTRA-RAPID SEPSIS BLOOD TEST

IDENTIFY SEPSIS UP TO 72 HOURS EARLIER

Image

SALIVA ANTIGEN TEST

ULTRA-RAPID COVID-19

Image

THE FIRST COVID-19 SEVERITY SCORE

FACILITATING PATIENT TRIAGE

abioSCOPE®

The innovative, Swiss-made in vitro diagnostic (IVD) rapid testing that…

10-9
… uses proprietary nanofluidic technology
1
… and just one drop of blood
14
… to analyse up to 14 parameters simultaneously…
5
… in about 5 minutes.
Abioscope Platform

THE abioSCOPE® PLATFORM

Provides healthcare professionals with cost-effective, ultra-rapid panel solutions at the point of care

DISRUPTIVE NANOFLUIDIC TECHNOLOGY

  • Rapid turnaround time
  • Laboratory-quality results
  • Easy handling for non-specialists

MULTIPLEX IMMUNOASSAY PANEL

  • Up to 14 parameters
  • Tailored panel options
  • One drop of capillary blood
Our primary commitment:

FIGHTING SEPSIS

FIVE MINUTES TO SAVE LIVES

As a member of the Global Sepsis Alliance (GSA), Abionic is an active ambassador in the fight against sepsis.

Logo

About Us

Abionic, based in the Biopôle life sciences campus in Lausanne, Switzerland, is developing and manufacturing in vitro diagnostic solutions using its proprietary disruptive nanofluidic technology.

The abioSCOPE® is the accomplishment of 10 years of R&D in the heart of the Swiss Health Valley.